Join our roundtable discussion for an in-depth analysis of Digital Health Cardiovascular Disease Ventures in North America’s Digital Health ecosystem.

About the Roundtable Discussion

Join leading industry experts for a roundtable discussion on digital health innovation for cardiovascular diseases.

The panel will be moderated by Gil Bashe, Chair Global Health & Purpose, FINN Partners, and will feature David Albert, MD, Founder & Chief Medical Officer, Alive Cor; Tal Wenderow, Venture Partner, Genesis Medtech Group; Julien de Salaberry, CEO & Co-Founder, Galen Growth; and Sara Schmachtenberg, Head of Data & Analytics – Europe & USA, Galen Growth.

Investment in this digital health category is just one of the many factors that define the possibilities. The key indicators of success are patient need, science, reimbursement, provider engagement, and outcomes. In this roundtable discussion, our experts will share their insights on these essential factors and more.

The discussion will cover topics such as:

  • Current state of digital health innovation for cardiovascular diseases
  • Patient needs and how they drive innovation
  • Science and technology behind innovative solutions
  • Reimbursement and regulatory challenges
  • Provider engagement and adoption
  • Outcomes and impact on patient care

Whether you are a healthcare professional, investor, or innovator interested in digital health solutions for cardiovascular diseases, this roundtable discussion is for you. Don’t miss this engaging session and get the latest insights from our experts.

About Digital Health in Cardiovascular Diseases

Don’t miss out on the opportunity to gain valuable insights into the Digital Health ecosystem in the Cardiovascular Disease Market. The report is now available on HealthTech Alpha.

This report is free to all Premium users of HealthTech Alpha, while a free version is available to all users of HealthTech Alpha. Don’t wait, access the report now and stay ahead of the curve in the Digital Health industry.

Source of Data

HealthTech Alpha, Galen Growth’s proprietary platform, is the data source for this report. HealthTech Alpha is the world’s most-trusted Digital Health data, intel, and insights platform, preferred by corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide. To find out more about our data, visit, or visit for our reports.

Our Mission

Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit